adverse effects

Can a point-of-care CRP test reduce antibiotic use in COPD?
Drug and Therapeutics Bulletin Jun 2020, 58 (6) 86; DOI: 10.1136/dtb.2020.000016
No benefit of faecal microbiota transplantation for IBS-D
Drug and Therapeutics Bulletin Jun 2020, 58 (6) 87; DOI: 10.1136/dtb.2020.000013
Reducing the risk of NSAID related gastrointestinal problems: an update
Martin Bradley

Drug and Therapeutics Bulletin Jun 2020, 58 (6) 89-92; DOI: 10.1136/dtb.2019.000072
What evidence for bisphosphonate drug holidays?
Drug and Therapeutics Bulletin Jun 2020, 58 (6) 88; DOI: 10.1136/dtb.2020.000017
Updated evidence for oral mucolytics in COPD
Drug and Therapeutics Bulletin Jul 2020, 58 (7) 102; DOI: 10.1136/dtb.2020.000015
What is the evidence for the use of potassium permanganate for wound care?
Varinder Rai

Drug and Therapeutics Bulletin May 2020, 58 (5) 71-74; DOI: 10.1136/dtb.2019.000064
No benefit from amitriptyline for chronic low back pain?
Teck K Khong, Kunal Lall

Drug and Therapeutics Bulletin Apr 2020, 58 (4) 53-54; DOI: 10.1136/dtb.2019.000088
Recent updates from the BNF
Drug and Therapeutics Bulletin Apr 2020, 58 (4) 55-56; DOI: 10.1136/dtb.2020.000019
Lung volume in COPD: when less is more
Jo Congleton

Drug and Therapeutics Bulletin Apr 2020, 58 (4) 50; DOI: 10.1136/dtb.2019.000082
EMA suspends licence for ingenol mebutate (Picato)
Drug and Therapeutics Bulletin Apr 2020, 58 (4) 51; DOI: 10.1136/dtb.2020.000012

Main menu